Cirrus Therapeutics
Breakthrough Gene Therapy for Dry AMD
Boston, United States · $11.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- cirrustx.com
- Total Funding
- $11.0M
- Last Round
- $11.0M SeedOct 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Ocular immunology company developing groundbreaking therapies for age-related macular degeneration and other retinal diseases.
Summary
Cirrus Therapeutics is a Biotech company based in Boston, United States. It has raised $11.0M in total across 1 round, most recently a $11.0M Seed round in Oct 2025. Investors include Polaris Partners, ClavystBio and LongGame.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cirrus-therapeutics"><img src="https://indexed.vc/api/badge/company/cirrus-therapeutics" alt="Cirrus Therapeutics on Indexed.vc" width="260" height="76" /></a>